Addressing the major challenges in conducting strategic and compliant late stage studies.
Come to Late Phase Drug Development World Europe 2011 and learn how to:
• Be efficient in demonstrating safety and effectiveness in large populations
• Collect, manage and present late phase study data in a way to demonstrate comparative effectiveness and outcomes research
• Use enabling technologies to aid late phase research
• Keep ahead of the game and meet the regulatory expectations for late phase research
• Maximise the full lifecycle of a product with the use of late phase studies to identify line extensions
Late Phase Drug Development World focuses on:
• Strategic drivers
• Regulatory environment
• Registries and results databases
• Enabling technologies in late stage development
• Operational issues in late stage study management
• Best practice case studies
Leading global and niche CROs attend:
- To showcase their expertise in late phase drug development
- To position their brand as leaders in late phase drug development
- To showcase solutions in phase IIIb/IV trials
- To generate leads and new business
Who should attend:
- Senior Directors & Heads in the following departments
- Risk Management
- Clinical Trials
- Clinical Research
- Post Marketing Surveillance
- Medical Affairs
- Pharmacoepidemiology
- Investigator Sponsored Studies
- Clinical Data Management
- Clinical Trial Registration
- Results Databases
- Drug Development
- Pharmacovigilance
Who should sponsor:
• CROs• Technology providers
There are limited sponsorship opportunities available so contact us as soon as possible for more information.
